# Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC Study

> **NCT02789540** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 900 (estimated)

## Conditions studied

- Stable COPD Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02789540
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-10
- **Primary completion:** 2016-10-31
- **Final completion:** 2016-10-31
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2017-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789540, "Latin American Study of 24-hs Symptoms in Chronic Obstructive Pulmonary Disease (COPD) Patients; LASSYC Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02789540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*